plerixafor has been researched along with Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, KF; Liu, CL; Mao, TL | 1 |
Antoon, JW; Beckman, BS; Burow, ME; Elliott, S; Muir, SE; Rhodes, LV | 1 |
Arita, Y; Kawashima, A; Koizumi, K; Minami, T; Nakayama, T; Saiki, I; Saitoh, Y; Sakurai, H; Shinohara, K; Takahashi, Y; Yasumoto, K; Yoshie, O | 1 |
3 other study(ies) available for plerixafor and Carcinoma
Article | Year |
---|---|
Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer.
Topics: Animals; Benzylamines; Carcinoma; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; Heterocyclic Compounds; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Ovarian Neoplasms; rac1 GTP-Binding Protein; Receptors, CXCR4; rhoA GTP-Binding Protein; RNAi Therapeutics | 2017 |
Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
Topics: Benzylamines; Breast Neoplasms; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Coculture Techniques; Cyclams; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Mesenchymal Stem Cells; Microscopy, Fluorescence; Receptors, CXCR4; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2010 |
Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer.
Topics: Animals; Ascites; Benzylamines; Carcinoma; Cell Line, Tumor; Chemokine CXCL12; Chemokines, CXC; Cyclams; Female; Heterocyclic Compounds; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Peritoneal Neoplasms; Receptors, CXCR4; Stomach Neoplasms; Transplantation, Heterologous | 2006 |